ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
binx health™ Submits Request for Emergency Use Authorization for First CRISPR-based Point-of-care Test for COVID-19
May 19, 2021Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences -
Turning CRISPR from a gene-editing hatchet to a ‘word processor’
May 08, 2018For all the excitement the gene-editing tool CRISPR-Cas9 has kicked up, there has been just as much concern about unwanted side effects. That’s because even though the technology offers the promise of cutting out disease-causing gene... -
Novartis, already up on CRISPR, CAR-T, looks to new gene editing R&D
November 14, 2017Novartis has penned a new deal with Homology Medicines as it looks to boost its already impressive R&D work in cell and gene therapy.
Pharma Sources Insight January 2025
